Advertisement: TTP Killer 50
2 July, 2018 - 12:51 By News Desk

MedImmune

With one of the largest, most robust pipelines in the industry – including more than 120 research projects and product candidates – AstraZeneca’s biologics division is focused on three core therapeutic areas: Oncology; Respiratory, Inflammation and Autoimmune; and Cardiovascular and Metabolic Disease.

It is also opportunity-driven in Infectious Disease.

medimmune.com

Newsletter Subscription

Stay informed of the latest news and features